Alimentos funcionales y nutracéuticos en el tratamiento de la hipercolesterolemia: posicionamiento de la Sociedad Española de Arteriosclerosis 2023

IF 1.9 Q3 PERIPHERAL VASCULAR DISEASE

Clinica e Investigacion en Arteriosclerosis Pub Date : 2023-09-01 DOI:10.1016/j.arteri.2023.02.002

Pablo Pérez-Martínez , Emilio Ros , Juan Pedro-Botet , Fernando Civeira , Vicente Pascual , Carmen Garcés , Rosa Solá , Francisco Pérez-Jiménez , José M. Mostaza

{"title":"Alimentos funcionales y nutracéuticos en el tratamiento de la hipercolesterolemia: posicionamiento de la Sociedad Española de Arteriosclerosis 2023","authors":"Pablo Pérez-Martínez , Emilio Ros , Juan Pedro-Botet , Fernando Civeira , Vicente Pascual , Carmen Garcés , Rosa Solá , Francisco Pérez-Jiménez , José M. Mostaza","doi":"10.1016/j.arteri.2023.02.002","DOIUrl":null,"url":null,"abstract":"<div><p>In the management of hypercholesterolemia, besides advising a healthy, plant-based diet, it may be useful to recommend functional foods or nutraceutical with cholesterol-lowering properties. Given the progressive increase in the number of these products and their rising use by the population, the Spanish Society of Arteriosclerosis (SEA) has considered it appropriate to review the available information, select the results of the scientifically more robust studies and take a position on their usefulness, to recommend to health professionals and the general population their potential utility in terms of efficacy and their possible benefits and limitations. The following clinical scenarios have been identified in which these products could be used and will be analyzed in more detail in this document: (1) Hypolipidemic treatment in subjects with statin intolerance. (2) Hypolipidemic treatment «a la carte» in individuals in primary prevention. (3) Long-term cardiovascular prevention in individuals with no indication for lipid-lowering therapy. (4) Patients with optimized lipid-lowering treatment who do not achieve therapeutic objectives.</p></div>","PeriodicalId":45230,"journal":{"name":"Clinica e Investigacion en Arteriosclerosis","volume":"35 5","pages":"Pages 248-261"},"PeriodicalIF":1.9000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica e Investigacion en Arteriosclerosis","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0214916823000098","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}

引用次数: 0

Abstract

In the management of hypercholesterolemia, besides advising a healthy, plant-based diet, it may be useful to recommend functional foods or nutraceutical with cholesterol-lowering properties. Given the progressive increase in the number of these products and their rising use by the population, the Spanish Society of Arteriosclerosis (SEA) has considered it appropriate to review the available information, select the results of the scientifically more robust studies and take a position on their usefulness, to recommend to health professionals and the general population their potential utility in terms of efficacy and their possible benefits and limitations. The following clinical scenarios have been identified in which these products could be used and will be analyzed in more detail in this document: (1) Hypolipidemic treatment in subjects with statin intolerance. (2) Hypolipidemic treatment «a la carte» in individuals in primary prevention. (3) Long-term cardiovascular prevention in individuals with no indication for lipid-lowering therapy. (4) Patients with optimized lipid-lowering treatment who do not achieve therapeutic objectives.

查看原文本刊更多论文

治疗高胆固醇血症的功能性和营养食品：2023年西班牙动脉硬化学会的定位

在高胆固醇血症的治疗中，除了建议健康的植物性饮食外，推荐具有降低胆固醇特性的功能性食品或营养品可能是有用的。鉴于这些产品的数量在逐渐增加，并且越来越多的人使用这些产品，西班牙动脉硬化学会（SEA）认为审查现有信息，选择科学上更有力的研究结果，并对其有用性采取立场是合适的，向卫生专业人员和普通人群推荐其在疗效方面的潜在效用及其可能的益处和局限性。这些产品可用于以下临床场景，并将在本文件中进行更详细的分析：（1）他汀类药物不耐受受试者的降脂治疗。（2）初级预防中个体的降血脂治疗“点菜”。（3）没有降脂治疗指征的个体的长期心血管预防。（4）接受优化降脂治疗但未达到治疗目标的患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinica e Investigacion en Arteriosclerosis PERIPHERAL VASCULAR DISEASE-

CiteScore

3.20

自引率

6.20%

发文量

审稿时长

40 days

期刊介绍： La publicación idónea para acceder tanto a los últimos originales de investigación como a formación médica continuada sobre la arteriosclerosis y su etiología, epidemiología, fisiopatología, diagnóstico y tratamiento. Además, es la publicación oficial de la Sociedad Española de Arteriosclerosis.